Background illustration for clinical trials search

COVID-19 Clinical Trials

Browse 377 COVID-19 clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Third Party Viral Specific T-cells (VSTs)

for
Viral Infection, Viral Reactivation,
Location: Akron OH, Columbus OH, Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT02532452

Phase 2, Recruiting

Using Furosemide to Prevent Fluid Overload During Red Blood Cell Transfusion in Neonates

for
Lung Disease
Location: Toronto
Sponsor: The Hospital for Sick Children

Sex: All

Age: 0

Code: NCT00618852

Phase 3, Recruiting

Comparing Centre-based, Remotely Supervised, and Self-administered STS Tests in Individuals With CRD

for
Chronic Lung Disease
Location: Toronto
Sponsor: West Park Healthcare Centre

Sex: All

Age: 18+

Code: NCT06479252

Recruiting

Advanced Prediction of Respiratory Depression Episode With the Linshom Continuous Predictive Respiratory Sensor

for
Post Surgical Respiratory Failure, Respiratory Complication
Location: Ellicott City MD, Columbus OH
Sponsor: Linshom Medical, Inc.

Sex: All

Age: 18+

Code: NCT05804175

Recruiting

Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock

for
Septic Shock, Sepsis, Pathologic Processes, Shock,
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT05969275

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19

for
Coronavirus Infection
Location: Seattle WA
Sponsor: Center for Integrated Care

Sex: All

Age: 18 - 70+

Code: NCT04380870

Recruiting

129 Xenon MRI in Chronic Lung Disease

for
Lung Disease
Location: London
Sponsor: Western University, Canada

Sex: All

Age: 18 - 70+

Code: NCT02723500

Recruiting

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

for
Asthma, COPD, Interstitial Lung Disease, Cystic Fibrosis,
Location: Kansas City KS
Sponsor: Mario Castro, MD, MPH

Sex: All

Age: 3+

Code: NCT04624490

Phase 1, Recruiting

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

for
Diabetes, Cholesterol, Cancer, Blood Pressure Disorders,
Location: Bryan TX
Sponsor: Texas A&M University

Sex: All

Age: 18+

Code: NCT06726590

Recruiting

The APS Phenotyping Study

for
ARDS, Sepsis, Pneumonia
Location: Philadelphia PA, Baltimore MD, Durham NC, Ann Arbor MI,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT06521502

Recruiting

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

for
Viral Infection
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 0+

Code: NCT04013802

Phase 1, Recruiting

Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration

for
Respiratory Disorders
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 18+

Code: NCT02316379

Phase 1, Phase 2, Recruiting

The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

for
Lower Respiratory Tract Infection
Location: Stony Brook NY, Brooklyn NY, Milwaukee WI, Dallas TX
Sponsor: MeMed Diagnostics Ltd.

Sex: All

Age: 18 - 70+

Code: NCT05762302

Recruiting

Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era

for
Corona Virus Infection
Location: Harrisburg PA
Sponsor: Pinnacle Health Cardiovascular Institute

Sex: All

Age: 0+

Code: NCT04636021

Recruiting

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

for
Chronic Lung Disease, Hematopoietic Cell Transplantation,
Location: Ann Arbor MI, Seattle WA, Stanford CA
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 3+

Code: NCT05866302

Recruiting

Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure

for
Infection, Alcohol Abuse, Drugs of Abuse, Lung Injury
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT02299921

Recruiting

Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults

for
Respiratory Disorders
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 6+

Code: NCT02272049

Phase 1, Phase 2, Recruiting

Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections

for
Pulmonary Disease, Critical Illness
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18 - 70+

Code: NCT06775106

Recruiting

Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics

for
Pneumonia
Location: Provo UT, Spanish Fork UT, Layton UT, American Fork UT,
Sponsor: Intermountain Health Care, Inc.

Sex: All

Age: 12+

Code: NCT04606849

Recruiting

Role of Lung Ultrasound and Pulsed-wave Doppler in Lung Consolidations in Mechanically Ventilated Patients

for
Atelectasis, Pneumonia
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT02100449

Recruiting

What is COVID-19?

COVID-19 is the illness caused by the SARS-CoV-2 virus, which spreads through the air and infects the airways and lungs, and sometimes other organs. For most people it now causes a short respiratory illness, but it can still lead to pneumonia, hospitalization, and death, above all in older adults, people with weakened immune systems, and those with conditions such as heart disease, diabetes, or lung disease. The virus keeps changing, so the vaccines are updated to match circulating variants, and antiviral pills work best when started within days of symptoms.

The first COVID-19 vaccines were authorized in December 2020, less than a year after the virus was identified, and they remain the main protection against severe illness. Treatment for people at higher risk includes antiviral medicines and, for those who cannot respond to vaccines, antibody based protection. Symptoms that last months after infection are a separate condition covered on our long COVID page.

Types of COVID-19 clinical trials

Who can participate in COVID-19 clinical trials?

Stages of COVID-19, and why they matter for trials

Do COVID-19 trial participants get paid?

How to enroll in a COVID-19 clinical trial